Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study
2024-01-01 Papi, Alberto; Forini, Giacomo; Maniscalco, Mauro; Bargagli, Elena; Crimi, Claudia; Santus, Pierachille; Molino, Antonio; Bandiera, Valeria; Baraldi, Federico; D'Anna, Silvestro Ennio; Carone, Mauro; Marvisi, Maurizio; Pelaia, Corrado; Scioscia, Giulia; Patella, Vincenzo; Aliani, Maria; Fabbri, Leonardo M
Type 2 severe asthma: pathophysiology and treatment with biologics
2024-01-01 Pelaia, Corrado; Melhorn, James; Hinks, Timothy Sc; Couillard, Simon; Vatrella, Alessandro; Pelaia, Girolamo; Pavord, Ian D
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study
2024-01-01 Crimi, Claudia; Nolasco, Santi; Noto, Alberto; Maglio, Angelantonio; Quaranta, Vitaliano Nicola; Di Bona, Danilo; Scioscia, Giulia; Papia, Francesco; Caiaffa, Maria Filomena; Calabrese, Cecilia; D'Amato, Maria; Pelaia, Corrado; Campisi, Raffaele; Vitale, Carolina; Ciampo, Luigi; Dragonieri, Silvano; Minenna, Elena; Massaro, Federica; Gallotti, Lorena; Macchia, Luigi; Triggiani, Massimo; Scichilone, Nicola; Valenti, Giuseppe; Pelaia, Girolamo; Foschino Barbaro, Maria Pia; Carpagnano, Giovanna Elisiana; Vatrella, Alessandro; Crimi, Nunzio
Interleukin 33: a suitable target for biological therapies of COPD?
2024-01-01 Pelaia, Corrado
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab
2024-01-01 Di Bona, Danilo; Bilancia, Massimo; Crimi, Claudia; Daddato, Michelina; Benfante, Alida; Caiaffa, Maria Filomena; Calabrese, Cecilia; Campisi, Raffaele; Nolasco, Santi; Carpagnano, Giovanna Elisiana; D'Amato, Maria; Pelaia, Corrado; Pelaia, Girolamo; Maglio, Angelantonio; Scichilone, Nicola; Scioscia, Giulia; Spadaro, Giuseppe; Triggiani, Massimo; Carrieri, Isabella; Valenti, Giuseppe; Vatrella, Alessandro; Macchia, Luigi; Crimi, Nunzio
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers
2023-01-01 Elisiana Carpagnano, Giovanna; nicola quaranta, Vitaliano; Crimi, Claudia; Santus, Pierachille; Menzella, Francesco; Pelaia, Corrado; Scioscia, Giulia; Caruso, Cristiano; Bargagli, Elena; Scichilone, Nicola; Polverino, Eva
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study
2020-01-01 Crimi, C.; Campisi, R.; Nolasco, S.; Cacopardo, G.; Intravaia, R.; Porto, M.; Impellizzeri, P.; Pelaia, C.; Crimi, N.
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
2023-01-01 Pelaia, C.; Pelaia, G.; Maglio, A.; Tinello, C.; Gallelli, L.; Lombardo, N.; Terracciano, R.; Vatrella, A.
Single inhaler LABA/LAMA for COPD
2019-01-01 Malerba, M.; Foci, V.; Patrucco, F.; Pochetti, P.; Nardin, M.; Pelaia, C.; Radaeli, A.
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting
2023-01-01 Vitale, C.; Maglio, A.; Pelaia, C.; D'Amato, M.; Ciampo, L.; Pelaia, G.; Molino, A.; Vatrella, A.
Allergy clinics in times of the SARS-CoV-2 pandemic: An integrated model
2020-01-01 Malipiero, G.; Heffler, E.; Pelaia, C.; Puggioni, F.; Racca, F.; Ferri, S.; Ferri, S.; Spinello, L.; Merigo, M.; Lamacchia, D.; Cataldo, G.; Sansonna, M.; Canonica, G. W.; Paoletti, G.
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study
2022-01-01 Quaranta, V. N.; Dragonieri, S.; Crimi, N.; Crimi, C.; Santus, P.; Menzella, F.; Pelaia, C.; Scioscia, G.; Caruso, C.; Bargagli, E.; Kostikas, K.; Kyriakopoulos, C.; Scichilone, N.; Carpagnano, G. E.
Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy
2022-01-01 Calabrese, C.; Annunziata, A.; Mariniello, D. F.; Coppola, A.; Mirizzi, A. I.; Simioli, F.; Pelaia, C.; Atripaldi, L.; Pugliese, G.; Guarino, S.; Fiorentino, G.
Type 2-high severe asthma with and without bronchiectasis: A prospective observational multicentre study
2021-01-01 Crimi, C.; Campisi, R.; Nolasco, S.; Ferri, S.; Cacopardo, G.; Impellizzeri, P.; Pistorio, M. P.; Fagone, E.; Pelaia, C.; Heffler, E.; Crimi, N.
Switching Biological Therapies in Severe Asthma
2023-01-01 Scioscia, G.; Nolasco, S.; Campisi, R.; Quarato, C. M. I.; Caruso, C.; Pelaia, C.; Portacci, A.; Crimi, C.
Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbidities
2020-01-01 Crimi, C.; Campisi, R.; Cacopardo, G.; Intravaia, R.; Nolasco, S.; Porto, M.; Pelaia, C.; Crimi, N.
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma
2021-01-01 Paoletti, G.; Melone, G.; Guida, G.; Pirola, F.; Malvezzi, L.; Pelaia, C.; Mariani, A.; Racca, F.; Malipiero, G.; Ferri, S.; Puggioni, F.; Spriano, G.; Canonica, G. W.; Heffler, E.
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study
2023-01-01 Maglio, A.; Vitale, C.; Pelaia, C.; D'Amato, M.; Ciampo, L.; Sferra, E.; Molino, A.; Pelaia, G.; Vatrella, A.
Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients
2021-01-01 Flora, M.; Perna, F.; Abbadessa, S.; Garziano, F.; Maffucci, R.; Maniscalco, M.; Mollica, M.; Pelaia, C.; Tremante, E.; Maffei, M.; Calabrese, C.
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
2020-01-01 Crimi, C.; Campisi, R.; Cacopardo, G.; Intravaia, R.; Nolasco, S.; Porto, M.; Pelaia, C.; Crimi, N.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study | 1-gen-2024 | Papi, Alberto; Forini, Giacomo; Maniscalco, Mauro; Bargagli, Elena; Crimi, Claudia; Santus, Pierachille; Molino, Antonio; Bandiera, Valeria; Baraldi, Federico; D'Anna, Silvestro Ennio; Carone, Mauro; Marvisi, Maurizio; Pelaia, Corrado; Scioscia, Giulia; Patella, Vincenzo; Aliani, Maria; Fabbri, Leonardo M | |
| Type 2 severe asthma: pathophysiology and treatment with biologics | 1-gen-2024 | Pelaia, Corrado; Melhorn, James; Hinks, Timothy Sc; Couillard, Simon; Vatrella, Alessandro; Pelaia, Girolamo; Pavord, Ian D | |
| Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study | 1-gen-2024 | Crimi, Claudia; Nolasco, Santi; Noto, Alberto; Maglio, Angelantonio; Quaranta, Vitaliano Nicola; Di Bona, Danilo; Scioscia, Giulia; Papia, Francesco; Caiaffa, Maria Filomena; Calabrese, Cecilia; D'Amato, Maria; Pelaia, Corrado; Campisi, Raffaele; Vitale, Carolina; Ciampo, Luigi; Dragonieri, Silvano; Minenna, Elena; Massaro, Federica; Gallotti, Lorena; Macchia, Luigi; Triggiani, Massimo; Scichilone, Nicola; Valenti, Giuseppe; Pelaia, Girolamo; Foschino Barbaro, Maria Pia; Carpagnano, Giovanna Elisiana; Vatrella, Alessandro; Crimi, Nunzio | |
| Interleukin 33: a suitable target for biological therapies of COPD? | 1-gen-2024 | Pelaia, Corrado | |
| Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab | 1-gen-2024 | Di Bona, Danilo; Bilancia, Massimo; Crimi, Claudia; Daddato, Michelina; Benfante, Alida; Caiaffa, Maria Filomena; Calabrese, Cecilia; Campisi, Raffaele; Nolasco, Santi; Carpagnano, Giovanna Elisiana; D'Amato, Maria; Pelaia, Corrado; Pelaia, Girolamo; Maglio, Angelantonio; Scichilone, Nicola; Scioscia, Giulia; Spadaro, Giuseppe; Triggiani, Massimo; Carrieri, Isabella; Valenti, Giuseppe; Vatrella, Alessandro; Macchia, Luigi; Crimi, Nunzio | |
| Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers | 1-gen-2023 | Elisiana Carpagnano, Giovanna; nicola quaranta, Vitaliano; Crimi, Claudia; Santus, Pierachille; Menzella, Francesco; Pelaia, Corrado; Scioscia, Giulia; Caruso, Cristiano; Bargagli, Elena; Scichilone, Nicola; Polverino, Eva | |
| Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study | 1-gen-2020 | Crimi, C.; Campisi, R.; Nolasco, S.; Cacopardo, G.; Intravaia, R.; Porto, M.; Impellizzeri, P.; Pelaia, C.; Crimi, N. | |
| Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis | 1-gen-2023 | Pelaia, C.; Pelaia, G.; Maglio, A.; Tinello, C.; Gallelli, L.; Lombardo, N.; Terracciano, R.; Vatrella, A. | |
| Single inhaler LABA/LAMA for COPD | 1-gen-2019 | Malerba, M.; Foci, V.; Patrucco, F.; Pochetti, P.; Nardin, M.; Pelaia, C.; Radaeli, A. | |
| Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting | 1-gen-2023 | Vitale, C.; Maglio, A.; Pelaia, C.; D'Amato, M.; Ciampo, L.; Pelaia, G.; Molino, A.; Vatrella, A. | |
| Allergy clinics in times of the SARS-CoV-2 pandemic: An integrated model | 1-gen-2020 | Malipiero, G.; Heffler, E.; Pelaia, C.; Puggioni, F.; Racca, F.; Ferri, S.; Ferri, S.; Spinello, L.; Merigo, M.; Lamacchia, D.; Cataldo, G.; Sansonna, M.; Canonica, G. W.; Paoletti, G. | |
| Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study | 1-gen-2022 | Quaranta, V. N.; Dragonieri, S.; Crimi, N.; Crimi, C.; Santus, P.; Menzella, F.; Pelaia, C.; Scioscia, G.; Caruso, C.; Bargagli, E.; Kostikas, K.; Kyriakopoulos, C.; Scichilone, N.; Carpagnano, G. E. | |
| Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy | 1-gen-2022 | Calabrese, C.; Annunziata, A.; Mariniello, D. F.; Coppola, A.; Mirizzi, A. I.; Simioli, F.; Pelaia, C.; Atripaldi, L.; Pugliese, G.; Guarino, S.; Fiorentino, G. | |
| Type 2-high severe asthma with and without bronchiectasis: A prospective observational multicentre study | 1-gen-2021 | Crimi, C.; Campisi, R.; Nolasco, S.; Ferri, S.; Cacopardo, G.; Impellizzeri, P.; Pistorio, M. P.; Fagone, E.; Pelaia, C.; Heffler, E.; Crimi, N. | |
| Switching Biological Therapies in Severe Asthma | 1-gen-2023 | Scioscia, G.; Nolasco, S.; Campisi, R.; Quarato, C. M. I.; Caruso, C.; Pelaia, C.; Portacci, A.; Crimi, C. | |
| Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbidities | 1-gen-2020 | Crimi, C.; Campisi, R.; Cacopardo, G.; Intravaia, R.; Nolasco, S.; Porto, M.; Pelaia, C.; Crimi, N. | |
| Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma | 1-gen-2021 | Paoletti, G.; Melone, G.; Guida, G.; Pirola, F.; Malvezzi, L.; Pelaia, C.; Mariani, A.; Racca, F.; Malipiero, G.; Ferri, S.; Puggioni, F.; Spriano, G.; Canonica, G. W.; Heffler, E. | |
| Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study | 1-gen-2023 | Maglio, A.; Vitale, C.; Pelaia, C.; D'Amato, M.; Ciampo, L.; Sferra, E.; Molino, A.; Pelaia, G.; Vatrella, A. | |
| Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients | 1-gen-2021 | Flora, M.; Perna, F.; Abbadessa, S.; Garziano, F.; Maffucci, R.; Maniscalco, M.; Mollica, M.; Pelaia, C.; Tremante, E.; Maffei, M.; Calabrese, C. | |
| Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities | 1-gen-2020 | Crimi, C.; Campisi, R.; Cacopardo, G.; Intravaia, R.; Nolasco, S.; Porto, M.; Pelaia, C.; Crimi, N. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista20604
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa16
- 2020 - 20255988
- 2010 - 20198339
- 2000 - 20093768
- 1990 - 19991806
- 1980 - 1989642
- 1973 - 197945
Editore
- Academic Press, Elsevier2
- Elsevier2
- Wiley-Blackwell2
- Betham Science Publishers Ltd1
- EDIZIONI MINERVA MEDICA1
- Elsevier Ltd1
- Frontiers Media S.A.1
- Harold H. Trimm, Willam Hunter1
- ieee1
- Morgan Kaufmann1
Rivista
- PLOS ONE177
- JOURNAL OF CLINICAL MEDICINE163
- INTERNATIONAL JOURNAL OF MOLECULA...118
- EPILEPSIA113
- THE JOURNAL OF CLINICAL ENDOCRINO...102
- NUTRIENTS101
- SCIENTIFIC REPORTS91
- NEUROLOGY85
- INTERNATIONAL JOURNAL OF MOLECULA...83
- INTERNATIONAL JOURNAL OF CARDIOLOGY78
Keyword
- Humans1109
- Female550
- Male481
- Aged326
- Middle Aged314
- COVID-19305
- Adult282
- Italy170
- SARS-CoV-2160
- Treatment Outcome153
Lingua
- eng15537
- ita2312
- spa40
- fre27
- ger20
- und11
- por2
- rus2
- aze1
- bos1
Accesso al fulltext
- no fulltext20570
- reserved25
- open9